GH Filing
4Filing Date: Jul 2, 2026

Guardant Health, Inc. (GH) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001871615-26-000014open_in_new
Total Value$536.4K
Trades9
Insiders1

Transaction Details

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Acquire
Common Stock
Shares+1.93K
Price$0.00
Total Value$0
Shares Owned After63.03K
Transaction DateJul 1, 2026
Freeman Chris
Chief Commercial Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-1.93K
Price$0.00
Total Value$0
Shares Owned After1.93K
Transaction DateJul 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. | Not applicable for Restricted Stock Units.

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-1.29K
Price$0.00
Total Value$0
Shares Owned After9.05K
Transaction DateJul 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Acquire
Common Stock
Shares+1.29K
Price$0.00
Total Value$0
Shares Owned After68.52K
Transaction DateJul 1, 2026
Freeman Chris
Chief Commercial Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-2.53K
Price$0.00
Total Value$0
Shares Owned After12.63K
Transaction DateJul 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Acquire
Common Stock
Shares+2.53K
Price$0.00
Total Value$0
Shares Owned After67.22K
Transaction DateJul 1, 2026
Freeman Chris
Chief Commercial Officer·Direct
Exercise · Acquire
Common Stock
Shares+1.67K
Price$0.00
Total Value$0
Shares Owned After64.70K
Transaction DateJul 1, 2026
Freeman Chris
Chief Commercial Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-3.14K
Price$170.77
Total Value$536.4K
Shares Owned After65.37K
Transaction DateJul 1, 2026
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Freeman Chris
Chief Commercial Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-1.67K
Price$0.00
Total Value$0
Shares Owned After1.67K
Transaction DateJul 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Post-Transaction Holdings

Freeman Chris
SecuritySharesChange
Common Stock63.03K+4.27K (7.27%)
Restricted Stock Units1.93K-7.41K (-79.35%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-01 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Freeman Chris CIK: 0001871615 Role: Officer (Chief Commercial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: +1,928 | Price: $0.00 Shares Owned After: 63,029 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: +1,667 | Price: $0.00 Shares Owned After: 64,696 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: +2,526 | Price: $0.00 Shares Owned After: 67,222 | Ownership: D (Direct) [Transaction #4] Security: Common Stock Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: +1,293 | Price: $0.00 Shares Owned After: 68,515 | Ownership: D (Direct) [Transaction #5] Security: Common Stock Date: 2026-07-01 | Code: F (Payment of exercise/tax) Shares: -3,141 | Price: $170.77 Total Value: $536,388.57 Shares Owned After: 65,374 | Ownership: D (Direct) Footnotes: [F1] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: -1,928 | Price: $0.00 Shares Owned After: 1,929 | Ownership: D (Direct) Footnotes: [F2] This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. [F3] Not applicable for Restricted Stock Units. [Transaction #2] Security: Restricted Stock Units Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: -1,667 | Price: $0.00 Shares Owned After: 1,668 | Ownership: D (Direct) Footnotes: [F4] This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. [Transaction #3] Security: Restricted Stock Units Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: -2,526 | Price: $0.00 Shares Owned After: 12,632 | Ownership: D (Direct) Footnotes: [F5] This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. [Transaction #4] Security: Restricted Stock Units Date: 2026-07-01 | Code: M (Exercise of derivative) Shares: -1,293 | Price: $0.00 Shares Owned After: 9,046 | Ownership: D (Direct) Footnotes: [F6] This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. --- Footnotes (Complete Index) --- F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. F2: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. F4: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. --- Signature --- /s/ /s/ John G. Saia, as attorney-in-fact for Chris Freeman (2026-07-02)

keid AI analysis is for reference only and does not constitute investment advice.